Patient Guide: Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 205 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04960709
Status: ACTIVE_NOT_RECRUITING
Condition: Urinary Bladder Neoplasms
Phase: PHASE3

Where You Can Participate

This study is available at 205 locations across the country.

Top locations include:
  • • Orange, California
  • • Santa Monica, California
  • • New Haven, Connecticut
  • • And 202 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin - Join Clinical Trial NCTNCT04960709

How to Join This Clinical Trial - NCTNCT04960709

Learn how to participate in this PHASE3 trial studying an investigational therapy for Urinary Bladder Neoplasms. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Urinary Bladder Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Urinary Bladder Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04960709 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 205 locations. Find a study site near you:

Clinical Research Site

Orange, California 92868 - United States

Status: Contact for availability

Clinical Research Site

Santa Monica, California 90404 - United States

Status: Contact for availability

Clinical Research Site

New Haven, Connecticut 06510 - United States

Status: Contact for availability

Clinical Research Site

Washington, District of Columbia 20010 - United States

Status: Contact for availability

Clinical Research Site

Fort Myers, Florida 33901 - United States

Status: Contact for availability

Clinical Research Site

Coeur d'Alene, Idaho 83814 - United States

Status: Contact for availability

Clinical Research Site

Maywood, Illinois 60153 - United States

Status: Contact for availability

Clinical Research Site

Indianapolis, Indiana 46250 - United States

Status: Contact for availability

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: Contact for availability

Clinical Research Site

Louisville, Kentucky 40207 - United States

Status: Contact for availability

And 195 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Urinary Bladder Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships